Edition:
United States

CymaBay Therapeutics Inc (CBAY.OQ)

CBAY.OQ on NASDAQ Stock Exchange Capital Market

7.78USD
3:59pm EST
Change (% chg)

$-0.33 (-4.07%)
Prev Close
$8.11
Open
$8.16
Day's High
$8.17
Day's Low
$7.76
Volume
103,108
Avg. Vol
191,109
52-wk High
$9.40
52-wk Low
$1.46

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Robert Wills

62 2015 Chairman of the Board

Sujal Shah

42 2017 President, Chief Executive Officer

Charles McWherter

62 Senior Vice President, Chief Scientific Officer

Daniel Menold

47 2017 Vice President - Finance, Principal Financial Officer, Principal Accounting Officer

Kirk Rosemark

44 2015 Vice President - Regulatory Affairs and Quality Assurance